ARIA - ARIAD Pharmaceuticals

Discussion in 'Stock Message Boards NYSE, NASDAQ, AMEX' started by StockJock-e, May 10, 2016.

Tags:
  1. StockJock-e

    StockJock-e Brew Master
    Staff Member

    Joined:
    Apr 3, 2016
    Messages:
    9,524
    Likes Received:
    3,526
    ARIAD Pharmaceuticals, Inc., an oncology company, engages in the discovery, development, and commercialization of drugs for cancer patients in the United States and internationally. It offers Iclusig (ponatinib), a tyrosine kinase inhibitor (TKI) for the treatment of adult patients with chronic myeloid leukemia (CML), and Philadelphia chromosome-positive acute lymphoblastic leukemia in the United States, the European Union, Australia, Switzerland, Israel, and Canada. The company also develops Brigatinib, an investigational inhibitor of anaplastic lymphoma kinase for the treatment of various patients with a form of non-small cell lung cancer; and AP32788, for treating non-small cell lung cancer and various other solid tumors. It markets and sells Iclusig through specialty pharmacy in the United States. The company has license agreements with Medinol Ltd. to develop and commercialize stents and other medical devices to deliver ridaforolimus. ARIAD Pharmaceuticals, Inc. was founded in 1991 and is headquartered in Cambridge, Massachusetts.

    [​IMG]
     
  2. StockJock-e

    StockJock-e Brew Master
    Staff Member

    Joined:
    Apr 3, 2016
    Messages:
    9,524
    Likes Received:
    3,526
    $8 resistance holding
     
  3. rg7803

    rg7803 Well-Known Member

    Joined:
    Apr 3, 2016
    Messages:
    577
    Likes Received:
    416
    Yep, we need a breakout at that level.
     
  4. StockJock-e

    StockJock-e Brew Master
    Staff Member

    Joined:
    Apr 3, 2016
    Messages:
    9,524
    Likes Received:
    3,526
    Big mover!

    +9% today!
     
  5. StockJock-e

    StockJock-e Brew Master
    Staff Member

    Joined:
    Apr 3, 2016
    Messages:
    9,524
    Likes Received:
    3,526
    CAMBRIDGE, Mass.--(BUSINESS WIRE)--


    ARIAD Pharmaceuticals, Inc. (ARIA) today announced initiation of the Phase 1/2 clinical trial of AP32788, an investigational tyrosine kinase inhibitor (TKI) designed as a targeted therapy for patients with non-small cell lung cancer (NSCLC) with specific mutations in EGFR or HER2. AP32788 targets tumors driven by EGFR or HER2 kinases and was designed to achieve selective inhibition of these kinases with exon 20 mutations. There are currently no approved targeted treatment options available for the approximately four to nine percent of EGFR-mutated lung tumors with exon 20 insertion mutations in NSCLC patients.1 Additionally, approximately two percent of NSCLC patients2 have HER2 mutations, with the majority having exon 20 insertion mutations.
     
    T0rm3nted likes this.
  6. Brendan Cowie

    Brendan Cowie Active Member

    Joined:
    Apr 4, 2016
    Messages:
    293
    Likes Received:
    42
    I have 20 Jan 2018 calls on this. 10$ strike

    Huge volume on them today
     
  7. T0rm3nted

    T0rm3nted Moderator
    Staff Member

    Joined:
    Apr 2, 2016
    Messages:
    8,448
    Likes Received:
    3,268
    Up 4.49% after hours to $9.31.
     
  8. StockJock-e

    StockJock-e Brew Master
    Staff Member

    Joined:
    Apr 3, 2016
    Messages:
    9,524
    Likes Received:
    3,526
    Back to 52wk highs!

    What a ride this stock is giving its shareholders!
     
  9. Brendan Cowie

    Brendan Cowie Active Member

    Joined:
    Apr 4, 2016
    Messages:
    293
    Likes Received:
    42
    I sold some short term calls for a 40% gain today
    Still holding 15 Jan 2018 10s
     
    StockJock-e likes this.
  10. fidelgeorge

    fidelgeorge Well-Known Member

    Joined:
    Apr 15, 2016
    Messages:
    971
    Likes Received:
    393
    Oil tanking, futures about to follow. ARIA has no support up here so should head lower. Retrace to low $8s min coming IMO
     
  11. LloydWCoutee

    LloydWCoutee Active Member

    Joined:
    May 4, 2016
    Messages:
    721
    Likes Received:
    58
    Ariad Pharmaceuticals's outperform rating reiterated at Cowen and Company. $10.00 PT.
     
    StockJock-e likes this.
  12. Brendan Cowie

    Brendan Cowie Active Member

    Joined:
    Apr 4, 2016
    Messages:
    293
    Likes Received:
    42
    disagree 10 is coming
     
  13. StockJock-e

    StockJock-e Brew Master
    Staff Member

    Joined:
    Apr 3, 2016
    Messages:
    9,524
    Likes Received:
    3,526
    Pharma rocking today!

    ARIA +5%
     
  14. Brendan Cowie

    Brendan Cowie Active Member

    Joined:
    Apr 4, 2016
    Messages:
    293
    Likes Received:
    42

    I knew it
     
  15. Brendan Cowie

    Brendan Cowie Active Member

    Joined:
    Apr 4, 2016
    Messages:
    293
    Likes Received:
    42
  16. Brendan Cowie

    Brendan Cowie Active Member

    Joined:
    Apr 4, 2016
    Messages:
    293
    Likes Received:
    42
    May see ITM tomorrow on my 2018s Still holding 17

    Had 25 at one point sold on the way up
     
    #16 Brendan Cowie, Sep 15, 2016
    Last edited: Sep 15, 2016
  17. Brendan Cowie

    Brendan Cowie Active Member

    Joined:
    Apr 4, 2016
    Messages:
    293
    Likes Received:
    42
    BEASTTTTTTTTTTTTTTTTTTTTTTTTTTTT
     
  18. Brendan Cowie

    Brendan Cowie Active Member

    Joined:
    Apr 4, 2016
    Messages:
    293
    Likes Received:
    42
    Beast mode again
     
  19. Brendan Cowie

    Brendan Cowie Active Member

    Joined:
    Apr 4, 2016
    Messages:
    293
    Likes Received:
    42
    Is nobody else watching this? Its up like 75% in 2 months
     
  20. Brendan Cowie

    Brendan Cowie Active Member

    Joined:
    Apr 4, 2016
    Messages:
    293
    Likes Received:
    42

Share This Page